| Literature DB >> 33309011 |
Pierre-Hadrien Becker1, Zeynep Demir2, Yael Mozer Glassberg3, Caroline Sevin4, Dalila Habes2, Apolline Imbard5, Charlotte Mussini6, Michal Rozenfeld Bar Lev3, Anne Davit-Spraul7, Jean-François Benoist5, Patrice Thérond1, Abdelhamid Slama8, Emmanuel Jacquemin9, Emmanuel Gonzales9, Pauline Gaignard10.
Abstract
Adenosine kinase (ADK) deficiency is characterized by liver disease, dysmorphic features, epilepsy and developmental delay. This defect disrupts the adenosine/AMP futile cycle and interferes with the upstream methionine cycle. We report the clinical, histological and biochemical courses of three ADK children carrying two new mutations and presenting with neonatal cholestasis and neurological disorders. One of them died of liver failure whereas the other two recovered from their liver damage. As the phenotype was consistent with a mitochondrial disorder, we studied liver mitochondrial respiratory chain activities in two patients and revealed a combined defect of several complexes. In addition, we retrospectively analyzed methionine plasma concentration, a hallmark of ADK deficiency, in a cohort of children and showed that methionine level in patients with ADK deficiency was strongly increased compared with patients with other liver diseases. ADK deficiency is a cause of neonatal or early infantile liver disease that may mimic primary mitochondrial disorders. In this context, an elevation of methionine plasma levels over twice the upper limit should not be considered as a nonspecific finding. ADK deficiency induced-liver dysfunction is most often transient, but could be life-threatening.Entities:
Keywords: ADK; Liver disease; Methionine; Mitochondrial respiratory chain; Neonatal cholestasis
Mesh:
Substances:
Year: 2020 PMID: 33309011 DOI: 10.1016/j.ymgme.2020.11.007
Source DB: PubMed Journal: Mol Genet Metab ISSN: 1096-7192 Impact factor: 4.797